BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21457141)

  • 21. Expression variability of absorption, distribution, metabolism, excretion-related microRNAs in human liver: influence of nongenetic factors and association with gene expression.
    Rieger JK; Klein K; Winter S; Zanger UM
    Drug Metab Dispos; 2013 Oct; 41(10):1752-62. PubMed ID: 23733276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retained introns increase putative microRNA targets within 3' UTRs of human mRNA.
    Tan S; Guo J; Huang Q; Chen X; Li-Ling J; Li Q; Ma F
    FEBS Lett; 2007 Mar; 581(6):1081-6. PubMed ID: 17320082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of microRNA expression by rifampin in human hepatocytes.
    Ramamoorthy A; Liu Y; Philips S; Desta Z; Lin H; Goswami C; Gaedigk A; Li L; Flockhart DA; Skaar TC
    Drug Metab Dispos; 2013 Oct; 41(10):1763-8. PubMed ID: 23935064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites.
    Lee I; Ajay SS; Yook JI; Kim HS; Hong SH; Kim NH; Dhanasekaran SM; Chinnaiyan AM; Athey BD
    Genome Res; 2009 Jul; 19(7):1175-83. PubMed ID: 19336450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of P450 Oxidoreductase Polymorphisms on the Metabolic Activities of Ten Cytochrome P450s Varied by Polymorphic CYP Genotypes in Human Liver Microsomes.
    Fang Y; Gao N; Tian X; Zhou J; Zhang HF; Gao J; He XP; Wen Q; Jia LJ; Jin H; Qiao HL
    Cell Physiol Biochem; 2018; 47(4):1604-1616. PubMed ID: 29949783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy.
    Preissner SC; Hoffmann MF; Preissner R; Dunkel M; Gewiess A; Preissner S
    PLoS One; 2013; 8(12):e82562. PubMed ID: 24340040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinformatics Analysis Revealed Novel 3'UTR Variants Associated with Intellectual Disability.
    Yang J; Liu A; He I; Bai Y
    Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32858868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
    Johansson I; Ingelman-Sundberg M
    Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioinformatic prediction of SNPs within miRNA binding sites of inflammatory genes associated with gastric cancer.
    Song CQ; Zhang JH; Shi JC; Cao XQ; Song CH; Hassan A; Wang P; Dai LP; Zhang JY; Wang KJ
    Asian Pac J Cancer Prev; 2014; 15(2):937-43. PubMed ID: 24568522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural modelling of the human drug-metabolizing cytochromes P450.
    Lewis DF; Ito Y; Goldfarb PS
    Curr Med Chem; 2006; 13(22):2645-52. PubMed ID: 17017916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in molecular modeling of human cytochrome P450 polymorphism.
    Martiny VY; Miteva MA
    J Mol Biol; 2013 Nov; 425(21):3978-92. PubMed ID: 23856621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics.
    Martinez MN; Antonovic L; Court M; Dacasto M; Fink-Gremmels J; Kukanich B; Locuson C; Mealey K; Myers MJ; Trepanier L
    Drug Metab Rev; 2013 May; 45(2):218-30. PubMed ID: 23432217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10.
    Augustin R; Endres K; Reinhardt S; Kuhn PH; Lichtenthaler SF; Hansen J; Wurst W; Trümbach D
    BMC Med Genet; 2012 May; 13():35. PubMed ID: 22594617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication.
    Tang X; Chen S
    Curr Drug Metab; 2015; 16(2):86-96. PubMed ID: 26179605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single nucleotide polymorphisms affect miRNA target prediction in bovine.
    Sousa MAP; de Athayde FRF; Maldonado MBC; Lima AO; Fortes MRS; Lopes FL
    PLoS One; 2021; 16(4):e0249406. PubMed ID: 33882076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico analysis of miRNA-mediated gene regulation in OCA and OA genes.
    Kamaraj B; Gopalakrishnan C; Purohit R
    Cell Biochem Biophys; 2014 Dec; 70(3):1923-32. PubMed ID: 25060099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional regulation of cytochrome p450 genes by the nuclear receptor hepatocyte nuclear factor 4-alpha.
    Jover R; Moya M; Gómez-Lechón MJ
    Curr Drug Metab; 2009 Jun; 10(5):508-19. PubMed ID: 19689247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absolute Quantitation of Drug-Metabolizing Cytochrome P450 Enzymes and Accessory Proteins in Dog Liver Microsomes Using Label-Free Standard-Free Analysis Reveals Interbreed Variability.
    Martinez SE; Shi J; Zhu HJ; Perez Jimenez TE; Zhu Z; Court MH
    Drug Metab Dispos; 2019 Nov; 47(11):1314-1324. PubMed ID: 31427433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic analysis of microRNA targeting impacted by small insertions and deletions in human genome.
    Bhattacharya A; Ziebarth JD; Cui Y
    PLoS One; 2012; 7(9):e46176. PubMed ID: 23049969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids.
    Dvorak Z; Pavek P
    Drug Metab Rev; 2010 Nov; 42(4):621-35. PubMed ID: 20482443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.